Scienture Holdings, Inc. (SCNX) income statement
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30
$2.55−0.21 (-7.61%)
Close on Nov 18, 2026Market cap $104.71MP/E –Yield –
Scienture Holdings, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 166.9%
- Operating margin
- -9284.1%
- Net margin
- -8793.2%
- Return on equity, FY2025
- -55.6%
Financial strength
- Current ratio
- 3.04
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 270.6%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.63
- Dividend yield
- –
See a number that looks wrong?